Shuanglu Pharmaceutical: At present, Jicabin has applied to the FDA for additional indications in the United States for the treatment of severe pneumonia for the treatment of pneumonia caused by new coronavirus infection – yqqlm

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000925 002038 002913 Aoshikang Technology Beijing Sl Pharmaceutical Unittec Pharmaceutical

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Shuanglu Pharmaceutical: At present, Jicabin has applied to the FDA for additional indications in the United States for the treatment of severe pneumonia for the treatment of pneumonia caused by new coronavirus infection – yqqlm